Orphans Find A Home
After years of neglect by pharma companies, rare disease treatment is coming into the limelight
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
May 13, 2013 Cover
Volume 91, Issue 19
After years of neglect by pharma companies, rare disease treatment is coming into the limelight
Cover image:
Credit:
After years of neglect by pharma companies, rare disease treatment is coming into the limelight
Chemists meet demand for novel ingredients that repair, add shine, and protect color
Unique properties could improve catalysis, batteries
Researchers obtain structure and propose mechanism of growth-signaling enzyme mTOR
Financial results reflect the economic challenges of 2012, but stock values point to optimism
Science is becoming increasingly important in diplomatic efforts at the State Department
Chromium-iron electrode smelts iron without the carbon dioxide